Atorvastatin and Antioxidants for the Treatment of Nonalcoholic Fatty Liver Disease: The St Francis Heart Study Randomized Clinical Trial
- 1 January 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in American Journal Of Gastroenterology
- Vol. 106 (1), 71-77
- https://doi.org/10.1038/ajg.2010.299
Abstract
OBJECTIVES: METHODS: RESULTS: CONCLUSIONS:Keywords
This publication has 36 references indexed in Scilit:
- Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial designContemporary Clinical Trials, 2008
- Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort StudyThe American Journal of Gastroenterology, 2008
- Statins in liver disease: A molehill, an iceberg, or neither?Hepatology, 2008
- A pilot study of atorvastatin treatment in dyslipemid, non‐alcoholic fatty liver patientsAlimentary Pharmacology & Therapeutics, 2006
- Nonalcoholic Fatty Liver Disease: From Steatosis to CirrhosisHepatology, 2006
- Pravastatin in patients with nonalcoholic steatohepatitis: results of a pilot studyAtherosclerosis, 2004
- A pilot study of pioglitazone treatment for nonalcoholic steatohepatitisHepatology, 2004
- Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndromeHepatology, 2003
- Atorvastatin for the treatment of NASHGastroenterology, 2001
- Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot studyThe Journal of Pediatrics, 2000